✦ LIBER ✦

Rosiglitazone and Cardiovascular Risk: Weighing Recent Evidence

✍ Scribed by Panagiotis C. Stafylas; Pantelis A. Sarafidis; Anastasios N. Lasaridis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rosiglitazone and cardiovascular risk

✍ Sanjay Kaul; George A. Diamond 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 267 KB

Is There Clear and Convincing Evidence o

✍ Kaul, S; Diamond, G A 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Rosiglitazone and the Risk of Adverse Ca

✍ Winterstein, A G 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 180 KB

Cardiovascular diseases and traffic acci

✍ Louise Potvin; Rémi Guibert; Jacynthe Loiselle 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 748 KB

Rosiglitazone, Myocardial Ischemic Risk,

✍ Bourg, C. A.; Phillips, B. B. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 207 KB

C-reactive protein and cardiovascular di

✍ Gordon D. O. Lowe; Mark B. Pepys 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 395 KB